formin in patients with Type 2 diabetes mellitus in-sufficiently controlled with diet and sulphonylureas:a randomized, placebo-controlled study. Diabet Med1999;16:755–761. 29. Wolffenbuttel BH, Landgraf R: A 1-year multicenter randomized double-blind comparison of repaglinideand glyburide for the treatment of type 2 diabetes.Dutch and German Repaglinide Study Group. Dia-betes Care 1999;22:463–467. 30. Ahren B, Simonsson E, Larsson H, Landin-Olsson M, Torgeirsson H, Jansson PA, Sandqvist M, BavenholmP, Efendic S, Eriksson JW, Dickinson S, Holmes D: In-hibition of dipeptidyl peptidase IV improves meta-bolic control over a 4-week study period in type 2 di-abetes. Diabetes Care 2002;25:869–875. 31. Tosi F, Muggeo M, Brun E, Spiazzi G, Perobelli L, Zanolin E, Gori M, Coppini A, Moghetti P: Combi-nation treatment with metformin and glibenclamideversus single-drug therapies in type 2 diabetes melli-tus: A randomized, double-blind, comparative study. Me-